← Leaderboards
Antonie H Rice
University Of Arkansas Med Scis Ltl Rock
$705,894
Attributed
$705,894
Total exposure
7
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $131.4K · FY2005–11$200K$150K$100K$50K$0
'05
'06
'07
'08
'09
'10
'11
Funding mix
By agency
NIH$705,894 · 7
By mechanism
P20$705,894 · 7
Top collaborators
No co-investigators on record.
Most similar at University Of Arkansas Med Scis Ltl Rock
Same institution · by research overlap
- Guido J. Tricot$3,260,370
- Timothy C Chambers$3,739,446
- Elizabeth Ann Coleman$1,917,908
- Bill J Gurle$2,022,387
- Joshua Epstein$6,765,629
Others in their field
Top investigators on “Resources”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$688,986,350
- Bambra Strokes · Ppd Development Lp$526,656,217
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Eric S Lander · Whitehead Institute For Biomedical Res$341,717,134
- Eric Jeffrey Topol · Cleveland Clinic Lerner Col/Med-Cwru$311,514,701
Research focus
ResourcesVectorPermeabilityPropertyUnited States National Institutes Of HealthUptakeNeuraxisPathway InteractionsP-GlycoproteinPharmaceutical PreparationsS DiseaseSourceBrainBrain NeoplasmsAlzheimer&AposModificationAffinityPaclitaxelAntineoplastic AgentsGrantBlood - Brain Barrier AnatomyFundingAnalogMicrotubules
Grant awards (8)
TARGETED DRUG DELIVERY OF ANTICANCER AGENTS ACROSS THE BLOOD-BRAIN BARRIER$119,513
P20 · FY2011 · RR · contact PI
ASSESSMENT OF DRUG UPTAKE AND PERMEABILITY PROPERTIES OF NOVEL ANTICANCER AGENT$121,269
P20 · FY2010 · RR · contact PI
ASSESSMENT OF DRUG UPTAKE AND PERMEABILITY PROPERTIES OF NOVEL ANTICANCER AGENT$100,272
P20 · FY2009 · RR · contact PI
ASSESSMENT OF DRUG UPTAKE AND PERMEABILITY PROPERTIES OF NOVEL ANTICANCER AGENT$131,375
P20 · FY2008 · RR · contact PI
ASSESSMENT OF DRUG UPTAKE AND PERMEABILITY PROPERTIES OF NOVEL ANTICANCER AGENT$112,327
P20 · FY2007 · RR · contact PI
ASSESSMENT OF DRUG UPTAKE AND PERMEABILITY PROPERTIES OF NOVEL ANTICANCER AGENT$104,145
P20 · FY2006 · RR · contact PI
ASSESSMENT OF DRUG UPTAKE AND PERMEABILITY PROPERTIES OF NOVEL ANTICANCER AGENTS$15,159
P20 · FY2005 · RR
DRUG UPTAKE AND PERMEABILITY OF NOVEL ANTICANCER AGENTS$1,834
P20 · FY2004 · RR